Coeptis Therapeutics Bolsa (NASDAQ: COEP)

Últimas noticias sobre Coeptis Therapeutics (NASDAQ:COEP) Bolsa

Coeptis Therapeutics

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

Movers

Trading Ideas

ARKR

AURA

BLRX

CHEK

CMCT

COEP

IDAI

LINC

MGOL

NINE

RSVR

Conoce las acciones que lideran el premercado tras movimientos clave: Check-Cap sube un 52,2% gracias a nueva patente.

Las acciones de Check-Cap suben un 52%; 20 acciones que se están moviendo antes de la apertura del mercado

Coeptis Therapeutics Holdings, Inc. - Common Stock

Coeptis Therapeutics Holdings Inc

Coeptis Therapeutics Holdings, Inc. - Warrants

Even while geopolitical tensions churn markets and institutional behemoths withdraw billions from one of the globe&#8217;s most <a href="https://www.benzinga.com/etfs">popular ETFs</a>, existing data implies long-term investors may be wise to stay put.
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), one of the largest and most liquid ETFs globally, was in downward pressure last week after tensions in the Middle East increased and investor anxiety rose. On Friday, SPY fell 1.1% to $597 after the S&amp;P 500 Index dropped below the symbolic 6,000 mark, following <a href="https://www.benzinga.com/markets/market-summary/25/06/45922513/global-markets-slide-as-iran-israel-conflict-heats-up-oil-soars">Israeli attacks on Iran </a>and heightened fears of a broader conflict.
Although it has currently pared the losses by Monday afternoon, question marks are flying above the investor cohort.
But even as headlines may be getting nerves on edge, a closer examination of data and some historical context paints a different picture.
<h1 class="wp-block-heading">$25 Billion SPY Selloff In Q1: What Are The Big Funds Seeing?</h1>
In the first quarter of 2025, institutional investors sold more than $25.2 billion of SPY, with Capula Management ($9.13 billion exit), Qube Research &amp; Technologies ($2.87 billion exit) and Bridgewater Associates ($2.80 billion exit) among the first to flee, based on <a href="https://hedgefollow.com/stocks/SPY">data </a>from Hedge Follow.
Though the magnitude of the sell-off is attention-grabbing, analysts note these actions are most likely tactical repositioning. This may possibly a hedge against geopolitical risk or a rotation into more defensive strategies, such as capping index-wide exposure in the near term, more than a pure bearish bet on U.S. stocks.
<h1 class="wp-block-heading">Market Declines Following Middle East Tensions Escalation</h1>
The SPY sell-off followed a larger decline among major U.S. indexes. The S&amp;P 500 dipped on Friday, retreating after a streak of strong growth. 
Driving the pullback were new worries about conflict in the Middle East. News of Israeli attacks on Iranian military sites revived concerns of a broader war in the region, with analysts speculating about the impact on global markets.
&#8220;The S&amp;P 500 is now in the middle of the Middle East,&#8221; said Ed Yardeni of Yardeni Research, who <a href="https://www.benzinga.com/markets/equities/25/06/45950097/war-shocks-could-drag-sp-500-down-5-but-market-typically-roars-back-heres-what-data-from-25-wars-70-years-shows">thinks the pullback is a buying opportunity</a>. This can also mean that now is a good entry point into SPY.
<h1 class="wp-block-heading">History Becomes The Mediator</h1>
While the headlines are dramatic, LPL Financial's Jeff Buchbinder points to a historical pattern of market resilience in the face of geopolitical conflict. 
In an analysis of 25 wars and military incidents over 70 years, LPL found that the S&amp;P 500 typically declines by just 5%, on average, during such events. More importantly, markets usually bottom within 19 days and recover their losses within 42. Indirectly, we can expect this strength to reflect in SPY as well.
<h1 class="wp-block-heading">To Dip, Or Not To Dip?</h1>
With SPY hitting a bump on the road, long-term investors are wondering if now is the moment to buy. As Wall Street whales are reducing exposure, strategists such as Louis Navellier warn that a big concern is that the conflict could expand.
Yet contrarian dissenters claim that dips driven by fear tend to benefit disciplined investors.
Stock futures are mostly unchanged this Sunday evening. Right or wrong, so far investors are believing Israel-Iran war is not a risk,&#8221; posted Nigam Arora of The Arora Report on X.
<h1 class="wp-block-heading">SPY May Be Down, But Not Out</h1>
Whereas short-term prospects are obscured by tensions on the global stage and top-of-page risk, past data indicates that SPY, and the U.S. market at large, has a demonstrated pattern of rebounding from such incidents.
For individual investors, it ultimately is a matter of time horizon and tolerance for risk. But if history is predictive, so-called panic selling amid geopolitical shocks does not often reward.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/etfs/sector-etfs/25/06/45956602/how-musks-political-drama-with-trump-steers-these-3-tesla-etfs">How Musk&#8217;s Political Drama With Trump Steers These 3 Tesla ETFs</a></li>
</ul>
Photo: Shutterstock

Long Ideas

Broad U.S. Equity ETFs

Hedge Funds

Global

ETFs

Big Money Dumps SPY, But History Says Don't Panic

Barrington Research analyst Gary Prestopino downgrades Cantaloupe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTLP#NASDAQ">CTLP</a>) from Outperform to Underperform.

News

Downgrades

Analyst Ratings

CTLP

Barrington Research Downgrades Cantaloupe to Underperform

Macquarie analyst Chad Beynon maintains Light &amp; Wonder (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNW#NASDAQ">LNW</a>) with a Outperform and raises the price target from $120 to $122.

Price Target

Macquarie Maintains Outperform on Light & Wonder, Raises Price Target to $122

<a href="https://www.washingtonpost.com/business/2025/06/16/trump-economist-business-tax-cuts-white-house/">https://www.washingtonpost.com/business/2025/06/16/trump-economist-business-tax-cuts-white-house/</a>

General

'Trump economist outlines case for business tax cuts, as GOP weighs bill'- Washington Post

On Friday, a day after Israel launched &#8220;Operation Rising Lion&#8221; targeting over 100 Iranian nuclear and military sites, Iran retaliated with missile <a href="https://www.benzinga.com/news/topics/25/06/45933856/iran-fires-ballistic-missiles-at-israel-tel-aviv-struck" target="_blank" rel="noreferrer noopener">attacks on Israel</a>. The strikes marked the start of what Iranian state media called &#8220;The Hard Retaliation.&#8221;
The state media confirmed the death of Iran&#8217;s Islamic Revolutionary Guard Corps (IRGC) Commander-in-Chief Hossein Salami. Israel&#8217;s Defense Ministry claimed most IRGC leadership was killed.
The conflict between Israel and Iran has had a notable impact on the <a target="_blank" href="https://www.benzinga.com/markets/macro-economic-events/25/06/45943707/us-economy-to-face-pretty-limited-impact-from-israel-iran-airstrikes-with-only-a-tiny-bit-recession-risk-say-economists" rel="noreferrer noopener">global financial markets</a>.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/equities/25/06/45944854/irans-missile-stockpile-may-be-shrinking-as-strikes-on-israel-taper-off-says-think-tank-lmt-rtx-" rel="noreferrer noopener">Iran&#8217;s Missile Stockpile May Be Shrinking As Strikes On Israel Taper Off, Says Think Tank: LMT, RTX, GD In Focus</a>
The&nbsp;Dow Jones index fell over&nbsp;700 points on Friday following Israel&#8217;s surprise airstrike on Iranian nuclear sites. Despite this, the&nbsp;CNN Money Fear and Greed index&nbsp;showed a&nbsp;decline&nbsp;in overall market sentiment, remaining in the &#8220;Greed&#8221; zone.
The&nbsp;SPDR Oil &amp; Gas Exploration &amp; Production ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOP#NYSE">XOP</a>) witnessed consistent demand throughout the week, recording five straight days of inflows. Weekly net investments hit $310 million, the fund&#8217;s <a target="_blank" href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/45948662/iran-israel-tensions-fuel-oil-rally-investors-are-piling-into-energy-etfs" rel="noreferrer noopener">second-strongest week of 2025</a>.
Other sector-focused ETFs trailed the energy fund&#8217;s inflows, with the&nbsp;Materials Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLB#NYSE">XLB</a>) pulling in $295 million and the&nbsp;Utilities Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>)&nbsp;attracting $267 million for the week.
D. Boral analyst Jesse Sobelson has expressed concerns that current market conditions are creating uncertainty for general equity investors. This uncertainty, in his view, could lead to a resurgence of inflation and increased volatility, particularly in sectors that are heavily reliant on <a target="_blank" href="https://www.benzinga.com/markets/commodities" rel="noreferrer noopener">raw material costs</a>.
Energy exploration and production (E&amp;P) stocks, especially U.S. companies with little exposure to the Middle East, might benefit from a sustained increase in oil prices, he pointed out.
He further emphasized that this situation exacerbates the already challenging OPEC+ negotiations as member countries grapple with escalating security risks and internal, often conflicting, priorities.
Sobelson posits that Tetra Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TTI#NYSE">TTI</a>) stands to gain if U.S. shale activity experiences a resurgence. He anticipates that an uptick in drilling by energy companies would directly increase demand for Tetra&#8217;s specialized water and chemical services, thereby boosting the company&#8217;s performance.
Pedevco Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PED#NYSE">PED</a>), which operates in the Permian Basin, could see strong gains if oil prices rise due to its high sensitivity to changes in crude prices, he asserted.
While more focused on natural gas, EON Resources Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EONR#NYSE">EONR</a>) has midstream assets and some oil-linked revenues that could rise with oil prices and support ongoing deal talks, Sobelson stated.
He emphasized that all three companies are particularly well-positioned for strong performance amidst a volatile, supply-constrained oil market.
The analyst stated, &#8220;We believe current oil prices embed an elevated&#8217; risk premium&#8217; due to the heightened probability of conflict spreading to critical oil infrastructure or shipping lanes. The Strait of Hormuz, responsible for approximately 20 million barrels per day of oil flow connecting the Persian Gulf to the Gulf of Oman, is specifically highlighted as a key piece of infrastructure to monitor closely.&#8221;
Price Action: TTI stock is up 3.2% at $3.6, EONR stock is down 11.1% at $0.51, and PED stock is down 4.32% at $0.73 at the last check on Monday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/06/45952716/stock-market-today-sp500-rises-iran-israel-nasdaq-near-record-highs" target="_blank" rel="noreferrer noopener">Wall Street Roars Back As Iran Signals De-Escalation: Nasdaq 100 Nears All-Time High</a></li>
</ul>
Photo via Shutterstock

Analyst Color

Penny Stocks

Markets

EONR

These Penny Stocks Stand To Gain From Israel-Iran Conflict Induced Volatility In Crude Oil: Analyst

<a href="https://www.bloomberg.com/news/articles/2025-06-16/israel-to-continue-strikes-despite-reports-iran-seeks-talks">https://www.bloomberg.com/news/articles/2025-06-16/israel-to-continue-strikes-despite-reports-iran-seeks-talks</a>

iShares MSCI Israel Capped Investable Market Index Fund

'Israel to Continue Strikes Despite Reports Iran Seeks Talks'- Bloomberg

WIIM

SHOP

Shopify shares are trading higher after DA Davidson maintained a Buy rating on the stock and raised its price target from $115 to $125.

<a href="https://www.bloomberg.com/news/articles/2025-06-16/moelis-incoming-ceo-sees-m-a-drivers-intact-during-mideast-wars?embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-06-16/moelis-incoming-ceo-sees-m-a-drivers-intact-during-mideast-wars?embedded-checkout=true</a>

'Moelis' Incoming CEO Sees M&A Drivers Intact During Mideast Wars'- Bloomberg

XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>) spiked over the past 24 hours as momentum builds ahead of a major catalyst. With rising key metrics, traders are eyeing significantly <a href="https://www.benzinga.com/topic/xrp">higher price levels</a>.  
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Market Cap</td>
<td>24-Hour Trend</td>
<td>7-Day Trend</td>
</tr>
<tr>
<td>XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td>&nbsp;$2.31</td>
<td>$136.6 billion</td>
<td>+7%&nbsp;</td>
<td>+0.99%&nbsp;</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>&nbsp;$107,906.56</td>
<td>$2.1 trillion</td>
<td>+2%&nbsp;</td>
<td>-0.4%&nbsp;</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>&nbsp;$2,638.18</td>
<td>$318.5 billion</td>
<td>+3.5%&nbsp;</td>
<td>+2.6%&nbsp;</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: Crypto trader Javon Marks believes XRP is in the early stages of a major bullish continuation. He cites a clean breakout and sets ambitious upside targets of $4.80 and $8.00.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24XRP&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$XRP</a> is holding a CLEAR BREAKOUT and can be getting ready for a MAJOR BULLISH CONTINUATION! Targets are at $4.80 and $8.00! <a href="https://t.co/pWhPpT3eLZ">pic.twitter.com/pWhPpT3eLZ</a>
&mdash; JAVON&#x26a1;&#xFE0F;MARKS (@JavonTM1) <a href="https://twitter.com/JavonTM1/status/1934619886568759654?ref_src=twsrc%5Etfw">June 16, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Trader CW <a href="https://x.com/CW8900/status/1934646107965190613">noted</a> that XRP is pressing against a significant sell wall. If it clears this resistance, the next key level to watch is $2.60.
Statistics: Crypto chart analyst Ali Martinez XRP active addresses soared to 1.12 million last week, signaling heightened on-chain activity.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24XRP&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$XRP</a> active addresses reached 1.12 million last week! <a href="https://t.co/BmZceEKFFk">pic.twitter.com/BmZceEKFFk</a>
&mdash; Ali (@ali_charts) <a href="https://twitter.com/ali_charts/status/1934622511389651104?ref_src=twsrc%5Etfw">June 16, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Coinglass reports that XRP&#8217;s open interest surged 11.4%, with derivatives trading volume up 123.3% in just one day. Total liquidations hit $7.2 million, with $5.7 million in short liquidations, the highest daily total since May 12, indicating traders betting against XRP were caught off guard by the rally.
Community News: Purpose Investments has <a href="https://www.globenewswire.com/news-release/2025/06/16/3100052/0/en/Purpose-XRP-ETF-Receives-OSC-Receipt-Set-to-Launch-on-TSX-on-Wednesday-June-18-2025.html">received</a> the final prospectus receipt for its Purpose XRP ETF, which is set to begin trading on the Toronto Stock Exchange (TSX) under the ticker XRPP on June 18. This marks a significant development in crypto finance, offering direct exposure to spot XRP for institutional and retail investors alike.
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45947210/bitcoin-ethereum-xrp-dogecoin-kick-off-week-in-green-but-btc-sell-signal-hints-at-pullback">Bitcoin, Ethereum, XRP, Dogecoin Kick Off Week In Green – But BTC Sell Signal Hints At Pullback</a></li>
</ul>
Photo: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$ETH

$XRP

XRP Jumps 7% In A Day – What's Fuelling The Surge?

<a href="https://www.cnbc.com/2025/06/16/amazon-kuiper-satellite-launch-delayed-by-ula-due-to-rocket-issue.html">https://www.cnbc.com/2025/06/16/amazon-kuiper-satellite-launch-delayed-by-ula-due-to-rocket-issue.html</a>

AMZN

'Amazon Kuiper second satellite launch postponed by ULA due to rocket booster issue'- CNBC

Citigroup Credit Card Delinquency Rate Was 1.39% At May End

Citigroup Credit Card Charge-Offs Was 2.33% In May

Equities

Large Cap

Sector ETFs

SPDR Dow Jones Industrial Average ETF Trust

PLTR

WYNN

Palantir Hits New Peak, AMD Rallies To 6-Month Highs: What's Driving Markets On Monday?

Rumors

CERT

Watching Certara; Traders Circulate Popular Newsletter Mentions Stock As A Buy

Japanese tech company Metaplanet has overtaken Coinbase Global Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) in Bitcoin holdings after acquiring an additional 1,112 BTC for $117.2 million, CEO Simon Gerovich announced Monday on X.
What Happened: The purchase, made at an average price of $105,435 per Bitcoin, pushed Metaplanet&#8217;s total holdings to 10,000 BTC. According to data from Bitcointreasuries.net, this positions the company ahead of Coinbase&#8217;s 9,267 BTC holdings, marking a significant shift in the corporate Bitcoin landscape.
Metaplanet&#8217;s stock surged 17.23% to 1,769 yen ($12.27) following the announcement. The company&#8217;s shares have gained over 408% year-to-date, reflecting investor enthusiasm for its Bitcoin accumulation strategy.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Metaplanet has acquired 1112 BTC for ~$117.2 million at ~$105,435 per bitcoin and has achieved BTC Yield of 266.1% YTD 2025. As of 6/16/2025, we hold 10,000 <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> acquired for ~$947 million at ~$94,697 per bitcoin. <a href="https://twitter.com/search?q=%24MTPLF&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$MTPLF</a> <a href="https://t.co/8nmQ2RaOIF">pic.twitter.com/8nmQ2RaOIF</a>
&mdash; Simon Gerovich (@gerovich) <a href="https://twitter.com/gerovich/status/1934445942536897019?ref_src=twsrc%5Etfw">June 16, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The Tokyo-based firm launched its Bitcoin acquisition program in April 2024 and recently revised its ambitious target to hold over 210,000 BTC by end-2027. This goal represents approximately 1% of Bitcoin&#8217;s total supply, positioning Metaplanet among the most aggressive corporate Bitcoin adopters globally.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">&#x2A;Metaplanet Announces Accelerated 2025-2027 Bitcoin Plan&#x2A; &#x2A;Targeting 210,000 <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> by 2027&#x2A; <a href="https://t.co/xJKu3J8Apb">pic.twitter.com/xJKu3J8Apb</a>
&mdash; Metaplanet Inc. (@Metaplanet_JP) <a href="https://twitter.com/Metaplanet_JP/status/1930892909001252869?ref_src=twsrc%5Etfw">June 6, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/crypto/25/06/45941991/bitcoin-ethereum-consolidate-dogecoin-dips-as-iran-israel-conflict-rages-on-these-levels-will-define-direction-of-btcs-next-breakout-says-analyst">Bitcoin, Ethereum Consolidate, Dogecoin Dips As Iran-Israel Conflict Rages On: These Levels Will Define Direction Of BTC&#8217;s Next Breakout, Says Analyst</a>
Why It Matters: While Metaplanet now exceeds Coinbase&#8217;s corporate holdings, MicroStrategy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) continues leading corporate Bitcoin ownership with 582,000 BTC following last week&#8217;s acquisition of 1,045 BTC. 
The Michael Saylor-led business intelligence firm pioneered the corporate Bitcoin treasury strategy that companies like Metaplanet have since adopted.
The milestone comes as Bitcoin trades at $107,193, with the cryptocurrency&#8217;s market capitalization reaching $2.13 trillion. 
Coinbase, despite being overtaken in corporate holdings, recently achieved its own milestone by becoming the first cryptocurrency exchange <a href="https://www.benzinga.com/trading-ideas/long-ideas/25/06/45932447/coinbase-sp-500-debut-new-products-offset-pressure">included in the S&amp;P 500 index</a>, signaling mainstream acceptance of the digital asset industry.
Read Next:&nbsp;&nbsp;&nbsp;&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45939432/bitcoins-current-cycle-sees-a-656-surge-matching-market-maturation-pace" target="_blank" rel="noreferrer noopener">Bitcoin's Current Cycle Sees A 656% Surge, Matching Market Maturation Pace</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

COIN

MSTR

Metaplanet Surpasses Coinbase In Bitcoin Holdings With $117 Million Purchase: Japan's Crypto Giant Now Targets 1% Of BTC Supply By 2027

Brunswick (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BC#NYSE">BC</a>) underwent analysis by 8 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Brunswick, presenting an average target of $57.0, a high estimate of $68.00, and a low estimate of $43.00. A 20.83% drop is evident in the current average compared to the previous average price target of $72.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1750096873_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
The standing of Brunswick among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>James Hardiman</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$68.00</td>
<td>$61.00</td>
</tr>
<tr>
<td>Craig Kennison</td>
<td>Baird</td>
<td>Raises</td>
<td>Neutral</td>
<td>$60.00</td>
<td>$56.00</td>
</tr>
<tr>
<td>Brandon Rolle</td>
<td>DA Davidson</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$43.00</td>
<td>$64.00</td>
</tr>
<tr>
<td>Gerrick Johnson</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$65.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Anna Glaessgen</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Hold</td>
<td>$45.00</td>
<td>$64.00</td>
</tr>
<tr>
<td>James Hardiman</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$59.00</td>
<td>$81.00</td>
</tr>
<tr>
<td>Michael Swartz</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$60.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Craig Kennison</td>
<td>Baird</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$56.00</td>
<td>$90.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Brunswick. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Brunswick compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Brunswick's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
To gain a panoramic view of Brunswick's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/BC/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Brunswick analyst ratings.</a>
<h2>About Brunswick</h2>
Brunswick is a leading manufacturer in the marine recreation industry. The firm has more than 60 brands delivering products across propulsion (outboard, sterndrive, and inboard engines, propulsion-related controls, rigging, and propellers), parts, accessories, and technology, and boats (including well-known brands like Boston Whaler and Sea Ray). It also owns numerous Freedom Boat Club locations as well as Boateka, which facilitates transactions in the used-boat market. Brunswick's focus surrounds building the innovative marine and recreational experiences, technologies, and connections supported by quality and innovation.
<h3>Unraveling the Financial Story of Brunswick</h3>
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
Decline in Revenue: Over the 3M period, Brunswick faced challenges, resulting in a decline of approximately -10.49% in revenue growth as of 31 March, 2025. This signifies a reduction in the company's top-line earnings. When compared to others in the Consumer Discretionary sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Brunswick's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 1.65%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Brunswick's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.07% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Brunswick's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 0.35%, the company showcases efficient use of assets and strong financial health.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 1.4, caution is advised due to increased financial risk.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Demystifying Brunswick: Insights From 8 Analyst Reviews

Across the recent three months, 4 analysts have shared their insights on AutoNation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AN#NYSE">AN</a>), expressing a variety of opinions spanning from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $197.25, a high estimate of $255.00, and a low estimate of $175.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 4.48%. 
<img src="https://www.benzinga.com/files/images/story/2025/1750096865_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
The standing of AutoNation among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>John Murphy</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$255.00</td>
<td>$225.00</td>
</tr>
<tr>
<td>Ronald Jewsikow</td>
<td>Guggenheim</td>
<td>Lowers</td>
<td>Buy</td>
<td>$183.00</td>
<td>$212.00</td>
</tr>
<tr>
<td>Colin Langan</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$176.00</td>
<td>$194.00</td>
</tr>
<tr>
<td>Rajat Gupta</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$175.00</td>
<td>$195.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to AutoNation. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of AutoNation compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of AutoNation's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of AutoNation's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/AN/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on AutoNation analyst ratings.</a>
<h2>Delving into AutoNation's Background</h2>
AutoNation is the second-largest automotive dealer in the United States, with 2024 revenue of about $27 billion and over 240 dealerships, plus 52 collision centers. The firm also has 26 AutoNation USA used-vehicle stores, a captive lender, four auction sites, and three parts distributors across 20 states primarily in Sunbelt metropolitan areas. New-vehicle sales account for nearly half of revenue; the company also sells used vehicles, parts, and repair services as well as auto financing. The company (formerly Republic Industries) divested its waste management unit (Republic Services) in 1999 and its car rental businesses (ANC Rental) in 2000. Wayne Huizenga founded the company in the 1990s to bring the rollup acquisition strategy to auto retailing, which has proved to be a smart move.
<h3>Unraveling the Financial Story of AutoNation</h3>
Market Capitalization: Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.
Revenue Growth: AutoNation's remarkable performance in 3M is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of 3.16%. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Consumer Discretionary sector.
Net Margin: AutoNation's net margin excels beyond industry benchmarks, reaching 2.62%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 7.22%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): AutoNation's ROA stands out, surpassing industry averages. With an impressive ROA of 1.33%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: AutoNation's debt-to-equity ratio is below the industry average at 3.76, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Breaking Down AutoNation: 4 Analysts Share Their Views

High-rolling investors have positioned themselves bearish on Capricor Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAPR#NASDAQ">CAPR</a>), and it's important for retail traders to take note. 
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in CAPR often signals that someone has privileged information.
Today, Benzinga's options scanner spotted 10 options trades for Capricor Therapeutics. This is not a typical pattern.
The sentiment among these major traders is split, with 20% bullish and 70% bearish. Among all the options we identified, there was one put, amounting to $29,500, and 9 calls, totaling $529,340.
<h3>What's The Price Target?</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $7.5 to $30.0 for Capricor Therapeutics over the recent three months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Capricor Therapeutics's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Capricor Therapeutics's significant trades, within a strike price range of $7.5 to $30.0, over the past month.
<h3>Capricor Therapeutics Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750096862_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CAPR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/15/27</td>
<td>$6.8</td>
<td>$5.6</td>
<td>$5.6</td>
<td>$17.50</td>
<td>$154.5K</td>
<td align="right">281</td>
<td align="right">376</td>
</tr>
<tr>
<td>CAPR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$6.9</td>
<td>$6.0</td>
<td>$6.0</td>
<td>$17.50</td>
<td>$60.0K</td>
<td align="right">281</td>
<td align="right">700</td>
</tr>
<tr>
<td>CAPR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$6.6</td>
<td>$5.6</td>
<td>$5.6</td>
<td>$17.50</td>
<td>$56.0K</td>
<td align="right">281</td>
<td align="right">576</td>
</tr>
<tr>
<td>CAPR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$6.6</td>
<td>$5.6</td>
<td>$5.6</td>
<td>$17.50</td>
<td>$56.0K</td>
<td align="right">281</td>
<td align="right">476</td>
</tr>
<tr>
<td>CAPR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$6.8</td>
<td>$5.6</td>
<td>$5.6</td>
<td>$17.50</td>
<td>$56.0K</td>
<td align="right">281</td>
<td align="right">0</td>
</tr>
</tbody>
</table>

<h3>About Capricor Therapeutics</h3>
Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat.
<h3>Current Position of Capricor Therapeutics</h3>
<ul>
<li>With a trading volume of 1,289,638, the price of CAPR is up by 0.25%, reaching $11.81.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 51 days from now.</li>
</ul>
<h3>What The Experts Say On Capricor Therapeutics</h3>
1 market experts have recently issued ratings for this stock, with a consensus target price of $77.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from HC Wainwright &amp; Co. downgraded its action to Buy with a price target of $77. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Capricor Therapeutics with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

Options

CAPR

Decoding Capricor Therapeutics's Options Activity: What's the Big Picture?

Whales with a lot of money to spend have taken a noticeably bearish stance on ConocoPhillips.
Looking at options history for ConocoPhillips (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COP#NYSE">COP</a>) we detected 11 trades.
If we consider the specifics of each trade, it is accurate to state that 27% of the investors opened trades with bullish expectations and 54% with bearish.
From the overall spotted trades, 6 are puts, for a total amount of $555,880 and 5, calls, for a total amount of $309,329.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $90.0 to $125.0 for ConocoPhillips over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
In today's trading context, the average open interest for options of ConocoPhillips stands at 4009.3, with a total volume reaching 9,699.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in ConocoPhillips, situated within the strike price corridor from $90.0 to $125.0, throughout the last 30 days.
<h3>ConocoPhillips 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750096857_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>COP</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$3.4</td>
<td>$2.91</td>
<td>$3.08</td>
<td>$90.00</td>
<td>$312.5K</td>
<td>607</td>
<td>1.0K</td>
</tr>
<tr>
<td>COP</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$0.25</td>
<td>$0.19</td>
<td>$0.22</td>
<td>$100.00</td>
<td>$121.0K</td>
<td>14.6K</td>
<td>5.6K</td>
</tr>
<tr>
<td>COP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$1.48</td>
<td>$1.21</td>
<td>$1.26</td>
<td>$125.00</td>
<td>$97.1K</td>
<td>2.3K</td>
<td>937</td>
</tr>
<tr>
<td>COP</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/21/25</td>
<td>$5.7</td>
<td>$5.6</td>
<td>$5.7</td>
<td>$90.00</td>
<td>$91.4K</td>
<td>638</td>
<td>280</td>
</tr>
<tr>
<td>COP</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>07/18/25</td>
<td>$2.05</td>
<td>$1.67</td>
<td>$1.89</td>
<td>$90.00</td>
<td>$56.7K</td>
<td>1.9K</td>
<td>325</td>
</tr>
</tbody>
</table>

<h3>About ConocoPhillips</h3>
ConocoPhillips is a US-based independent exploration and production firm. In 2024, it produced 2.0 million barrels per day of oil and natural gas liquids and 3.4 billion cubic feet per day of natural gas, primarily from Alaska and the Lower 48 in the United States and Norway in Europe and several countries in Asia-Pacific and the Middle East. Proven reserves at year-end 2024 were 7.8 billion barrels of oil equivalent.
<h3>ConocoPhillips's Current Market Status</h3>
<ul>
<li>With a trading volume of 5,890,636, the price of COP is down by -1.75%, reaching $95.26.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 45 days from now.</li>
</ul>
<h3>What Analysts Are Saying About ConocoPhillips</h3>
Over the past month, 4 industry analysts have shared their insights on this stock, proposing an average target price of $111.25.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from RBC Capital keeps a Outperform rating on ConocoPhillips with a target price of $115. 
&#x2A; Maintaining their stance, an analyst from Citigroup continues to hold a Buy rating for ConocoPhillips, targeting a price of $115. 
&#x2A; Consistent in their evaluation, an analyst from B of A Securities keeps a Neutral rating on ConocoPhillips with a target price of $106. 
&#x2A; Maintaining their stance, an analyst from Raymond James continues to hold a Outperform rating for ConocoPhillips, targeting a price of $109. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for ConocoPhillips, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Decoding ConocoPhillips's Options Activity: What's the Big Picture?

Analysts' ratings for KeyCorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEY#NYSE">KEY</a>) over the last quarter vary from bullish to bearish, as provided by 10 analysts.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated KeyCorp and provided 12-month price targets. The average target is $18.35, accompanied by a high estimate of $20.00 and a low estimate of $16.00. Highlighting a 5.36% decrease, the current average has fallen from the previous average price target of $19.39. 
<img src="https://www.benzinga.com/files/images/story/2025/1750096856_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
The standing of KeyCorp among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Erika Najarian</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$20.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>David Chiaverini</td>
<td>Jefferies</td>
<td>Announces</td>
<td>Hold</td>
<td>$18.00</td>
<td>-</td>
</tr>
<tr>
<td>Brian Foran</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$16.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>David Konrad</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$18.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Jason Goldberg</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$20.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>David George</td>
<td>Baird</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$18.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Vivek Juneja</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$16.50</td>
<td>$18.50</td>
</tr>
<tr>
<td>Mike Mayo</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$20.00</td>
<td>$22.00</td>
</tr>
<tr>
<td>Keith Horowitz</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$19.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Brian Foran</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$18.00</td>
<td>$19.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to KeyCorp. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of KeyCorp compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of KeyCorp's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/KEY/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on KeyCorp analyst ratings.</a>
<h2>Get to Know KeyCorp Better</h2>
With assets of over $185 billion, Ohio-based KeyCorp's bank footprint spans 16 states, but it is predominantly concentrated in its two largest markets: Ohio and New York. KeyCorp is primarily focused on serving middle-market commercial clients through a hybrid community/corporate bank model.
<h3>Key Indicators: KeyCorp's Financial Health</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: KeyCorp's revenue growth over a period of 3M has been noteworthy. As of 31 March, 2025, the company achieved a revenue growth rate of approximately 16.41%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Financials sector.
Net Margin: KeyCorp's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of 21.4%, the company may face hurdles in effective cost management.
Return on Equity (ROE): KeyCorp's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 2.29%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): KeyCorp's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.2%, the company may face hurdles in achieving optimal financial performance.
Debt Management: KeyCorp's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.89.
<h2>Analyst Ratings: What Are They?</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Breaking Down KeyCorp: 10 Analysts Share Their Views

Press Releases

COEPTIS Partners with NexGenAI Solutions Group to Launch New AI Co-Working Hub in India, Driving Global Innovation in Technology

COEPTIS (COEP) Expands Global Footprint with Strategic India Tech Hub

Biotech

Coeptis Therapeutics, Inc. and Z Squared Inc. Announce Merger Agreement

COEP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Coeptis Therapeutics Holdings, Inc. Is Fair to Shareholders

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Coeptis Therapeutics Holdings, Inc. - COEP

Legal

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPTN, COEP, SWTX, CKPT on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates COEP and PPBI on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RGLS, KRON, PPBI, COEP on Behalf of Shareholders

NUBURU Files $100M SEC Registration Statement to Enhance Capital Flexibility for Completion of Defense Acquisition and Blue Laser Technology Revitalization Targeting a $500B Defense Market

Monarch Therapeutics and SNAP Biosciences, Inc., a Subsidiary of Coeptis Therapeutics Holdings Inc., Enter Licensing Agreement to Bolster SNAP-CAR NK Cell Therapy in Oncology

BURU

CKPT

HOOD

KRON

MARA

OPTN

PPBI

PYPL

RGLS

RIOT

SWTX

ABVC BioPharma

ALX Oncology Holdings Inc. - Common Stock

ALX Oncology Holdings

Barinthus Biotherapeutics plc - American Depositary Shares

Barinthus Biotherapeutics

CAMP4 Therapeutics Corporation - Common Stock

Camp4 Therapeutics

CASI Pharmaceuticals, Inc. - Ordinary Shares

CASI Pharmaceuticals

Clene

Curis

Dyadic International, Inc. - Common Stock

Dyadic International

Estrella Immunopharma, Inc. - Common Stock

Estrella Immunopharma

FibroBiologics

FibroGen

Generation Bio

Imunon

MiNK Therapeutics

Kala Bio

Kezar Life Sciences

Lantern Pharma

Nanoviricides

OnKure Therapeutics, Inc. - Class A Common Stock

OnKure Therapeutics

OSR Holdings

Passage Bio

Pluri

Shuttle Pharmaceuticals Holdings, Inc. - common stock

Shuttle Pharmaceuticals

Tempest Therapeutics, Inc. - Common Stock

Comments

Coeptis Therapeutics

Noticias

Últimas noticias sobre Coeptis Therapeutics (NASDAQ:COEP) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL